Zobrazeno 1 - 10
of 134
pro vyhledávání: '"ZHITONG BING"'
Publikováno v:
Frontiers in Genetics, Vol 15 (2024)
BackgroundR3HDM1, an RNA binding protein with one R3H domain, remains uncharacterized in terms of its association with tumor progression, malignant cell regulation, and the tumor immune microenvironment. This paper aims to fill this gap by analyzing
Externí odkaz:
https://doaj.org/article/01e37dc360af408797c76b31358dd903
Publikováno v:
Campbell Systematic Reviews, Vol 19, Iss 4, Pp n/a-n/a (2023)
Abstract This is the protocol for a Campbell systematic review. The objectives are as follows. The objectives of the present study are to answer the following questions: (1) What types of home‐based interventions are currently being studied to prev
Externí odkaz:
https://doaj.org/article/3cd931928f0e408a8aa56b0fb7eb210f
Autor:
Hongyan Li, Hong Zhang, Guomin Huang, Zhitong Bing, Duling Xu, Jiadi Liu, Hongtao Luo, Xiaoli An
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-20 (2022)
Abstract Background Depletion of certain ribosomal proteins induces p53 activation, which is mediated mainly by ribosomal protein L5 (RPL5) and/or ribosomal protein L11 (RPL11). Therefore, RPL5 and RPL11 may link RPs and p53 activation. Thus, this st
Externí odkaz:
https://doaj.org/article/7fedad03fa6f484e83c132895bc5bf96
Publikováno v:
ACS Omega, Vol 6, Iss 49, Pp 33864-33873 (2021)
Externí odkaz:
https://doaj.org/article/b654ba32256c4d2daca2a11b063354be
Autor:
Fengling Wang, Wenling Ye, Shuang Wang, Yongxing He, Haiyang Zhong, Yuwei Wang, Yongchang Zhu, Jianting Han, Zhitong Bing, Shaoping Ji, Huanxiang Liu, Xiaojun Yao
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 3, Pp 281-293 (2021)
Blockade of the PD-1/PD-L1 immunologic checkpoint using monoclonal antibodies has provided breakthrough therapies against cancer in the recent years. Nevertheless, intrinsic disadvantages of therapeutic antibodies may limit their applications. Thus,
Externí odkaz:
https://doaj.org/article/8ccac2f9f518430f951d7e8eabfbcca6
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 19, Iss , Pp 3978-3989 (2021)
Activation of human free fatty acid receptor 1 (FFAR1, also called hGPR40) enhances insulin secretion in a glucose-dependent manner. Hence, the development of selective agonist targeting hGPR40 has been proposed as a therapeutic strategy of type 2 di
Externí odkaz:
https://doaj.org/article/ef14d48b7d164e7396149f781c96a929
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Owing to metastases and drug resistance, the prognosis of breast cancer is still dismal. Therefore, it is necessary to find new prognostic markers to improve the efficacy of breast cancer treatment. Literature shows a controversy between moesin (MSN)
Externí odkaz:
https://doaj.org/article/91476c6ba7994e6f9162414a64c054c6
Publikováno v:
PeerJ, Vol 9, p e11350 (2021)
Background Gliomas are the most common primary tumors of the central nervous system. The complexity and heterogeneity of the tumor makes it difficult to obtain good biomarkers for drug development. In this study, through The Cancer Genome Atlas (TCGA
Externí odkaz:
https://doaj.org/article/585701b5e83047f1bca9997364ee2734
Autor:
Qingzong Si, Qian Ye, Zhitong Bing, Ruihong Fan, Xiaoli Hu, Bin Liu, Jizeng Wang, Yang Liu, Xiaoli An
Publikováno v:
Frontiers in Public Health, Vol 9 (2021)
Oral cancer is a very aggressive disease with high rates of recurrence and metastasis. This study aimed at addressing how efficiently tongue cancer is suppressed after carbon ion irradiation. Here, the close relationship between upregulated expressio
Externí odkaz:
https://doaj.org/article/fe70633fa13c435c817f9b8559320d7b
Publikováno v:
PeerJ, Vol 8, p e10297 (2020)
Background Pancreatic cancer (PC) has much weaker prognosis, which can be divided into diabetes and non-diabetes. PC patients with diabetes mellitus will have more opportunities for physical examination due to diabetes, while pancreatic cancer patien
Externí odkaz:
https://doaj.org/article/59f6d2f5e7774133afa04623cbfc613b